Experts state that the country’s generic exports are now growing at around 22 % per year, with India accounting for around 20-22 % of the world’s production.

The major turnaround of the Porvoo refinery in Finland which was earlier planned for this year has now been postponed due to the global pandemic of Covid-19. The company will now be carrying out the turnaround in phases and is expected to execute only the most business critical maintenance works and regulatory inspections in April - June 2020.

Toray has developed a new variety of regular tow carbon fiber and has decided to build a new carbonization facility for mass production at the Mexico Plant (Jalisco) of its US subsidiary Zoltek to cater to the strongly growing carbon fiber demand. The new plant is expected to start production at the end of 2018.

Two birds with one stone: Operators can use the variable speed rotor mill Pulverisette 14 in its Premium Line incarnation both for milling and cutting applications.

Roche has collaborated with the Biomedical Advanced Research and Development Authority to kick-start the vital study which is expected to evaluate the safety of the Actemra drug for adult patients with severe Covid-19 pneumonia. The company has also introduced testing solutions to detect the virus.

Lipigon Pharmaceuticals has entered into a research, development and transfer agreement with Secarna Pharmaceuticals. Under the terms of the agreement, Lipigon Pharmaceuticals will continue to develop the acquired antisense drug candidates targeting the Angptl gene family.

Named as ‘Technological Development Group of Environmental Initiatives’, the R&D Group will be established by Sumitomo Chemical in Japan’s Petrochemicals Research Laboratory. The goal of the Group is to utilise core technologies in order to create a process which reduces environmental impact.

Bioconstruct has been appointed with the construction of an 844 kW biogas plant near Thessaloniki, in Sochos, Greece. This contract continues the company's internationalization and marks the entry into a ninth European market.

Immunogenesis has entered into a Service Agreement with Probiogen. Under the terms of the contract, Probiogen will support Immunogenesis’ cell line development and also conduct large-scale manufacturing in its new facility.

With the expansion, Klӧckner Pentaplast has increased its coating capacity by over 30 % and aims to support the growing South American pharmaceutical market. The facility will offer customers with high quality and innovative pharmaceutical packaging films with shorter lead times.